SCIENTIFIC HUB

Araştırmanın izini sürün.

SCIENTIFIC LITERATURE · MED

Seed amplification of released alpha-synuclein strains reveals genotype-specific differences in Parkinson's disease neurons.

Front Aging Neurosci · 2026-09-08

DOI: 10.3389/fnagi.2026.1917981PMID: 42774389

Open accessresearch-article; Journal ArticleKaynağa git ↗

Araştırma özeti

Aşağıdaki metin kaynak makalenin lisansı doğrulanmış orijinal özetidir. cc by

Parkinson's disease is one of a group of diseases collectively termed α-synucleinopathies, all of which are characterized by abnormal accumulation of toxic α-synuclein (α-syn) assemblies which are thought to follow a prion-like propagation model and drive neuronal death. Both intrinsic strain properties and the genetic background of affected individuals are hypothesized to influence α-syn aggregate accumulation, propagation, and extracellular release. As such, the aim of this study is to characterize how different genetic backgrounds modulate α-syn aggregate accumulation and release in response to treatment with different α-syn strains. iPSC-derived neurons from five different groups were employed (healthy non-PD controls (NPC), idiopathic PD (iPD), GBA1 N370S, LRRK2 G2019S and SNCA A53T) (n = 15 cell lines, three lines per group). Individual aggregates in conditioned medium (CM) were measured using a single-particle detection system to quantify released α-syn species and assess strain persistence across genotype groups. Seed amplification assay (SAA) was then applied and linear discriminant analysis (LDA) of single particle properties from CM of α-syn fibril-treated neurons was used to discriminate between groups. α-Syn released into CM showed strain persistence in LRRK2 G2019S and GBA1 N370S genotype groups, while SNCA A53T neurons exhibited evidence of strain remodeling. Interestingly, amplification-response Δ-feature analysis of single particle properties showed group discrimination beyond either pre- or post- amplification measurements independently, reaching a maximum LOO-CV accuracy of 66.7% (3.3 × chance level) at day 10 post-treatment in CM from fibrils-treated neurons. These findings indicate that genotype-specific cellular responses differentially shape the structural properties of released α-syn in a manner that determines amplification responses, enabling inter-group discrimination at the single-molecule level.

Bilimsel değerlendirme

01

Araştırma sorusu

Sorunun kapsamı orijinal çalışma üzerinden değerlendirilir.

02

Yöntem ve örneklem

Çalışma tasarımı ve örneklem için kaynak makaleyi kontrol edin.

03

Temel bulgular

Bu kayıt için editoryal olarak onaylanmış bulgu özeti henüz yayımlanmadı.

04

Sınırlılıklar

Sonuçların genellenebilirliği, yanlılık ve klinik anlamı ayrıca incelenmelidir.

Bibliyografik veriden yöntem, örneklem veya klinik sonuç çıkarımı yapılmaz.